FI750816A - - Google Patents

Info

Publication number
FI750816A
FI750816A FI750816A FI750816A FI750816A FI 750816 A FI750816 A FI 750816A FI 750816 A FI750816 A FI 750816A FI 750816 A FI750816 A FI 750816A FI 750816 A FI750816 A FI 750816A
Authority
FI
Finland
Application number
FI750816A
Other languages
Finnish (fi)
Inventor
Ikuo Ueda
Masaaki Matsuo
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI750816A publication Critical patent/FI750816A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/22Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI750816A 1974-03-20 1975-03-19 FI750816A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49031905A JPS5919099B2 (ja) 1974-03-20 1974-03-20 2−置換チオ−1,4−ベンゾジアゼピン誘導体の製造法

Publications (1)

Publication Number Publication Date
FI750816A true FI750816A (ja) 1975-09-21

Family

ID=12344003

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750816A FI750816A (ja) 1974-03-20 1975-03-19

Country Status (15)

Country Link
JP (1) JPS5919099B2 (ja)
AU (1) AU7929875A (ja)
BE (1) BE826817A (ja)
CA (1) CA1064029A (ja)
DE (1) DE2511898A1 (ja)
DK (1) DK114175A (ja)
ES (1) ES435812A1 (ja)
FI (1) FI750816A (ja)
FR (1) FR2264545B1 (ja)
GB (1) GB1467763A (ja)
HU (1) HU170141B (ja)
NL (1) NL7503269A (ja)
NO (1) NO750943L (ja)
SE (1) SE7503164L (ja)
ZA (1) ZA751715B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094870A (en) * 1974-03-20 1978-06-13 Fujisawa Pharmaceutical Co., Ltd. 2-Substituted thio-1,4-benzodiazepine derivatives

Also Published As

Publication number Publication date
ES435812A1 (es) 1976-12-01
DK114175A (ja) 1975-09-21
BE826817A (fr) 1975-09-18
DE2511898A1 (de) 1975-09-25
SE7503164L (ja) 1975-09-22
JPS5919099B2 (ja) 1984-05-02
HU170141B (ja) 1977-04-28
NL7503269A (nl) 1975-09-23
FR2264545A1 (ja) 1975-10-17
NO750943L (ja) 1975-09-23
AU7929875A (en) 1976-09-23
FR2264545B1 (ja) 1978-08-04
GB1467763A (en) 1977-03-23
CA1064029A (en) 1979-10-09
ZA751715B (en) 1976-02-25
JPS50131980A (ja) 1975-10-18

Similar Documents

Publication Publication Date Title
FR2294489B1 (ja)
FR2272969A1 (ja)
FR2272468A1 (ja)
FR2265976A1 (ja)
FR2270428B3 (ja)
FR2264477B1 (ja)
FR2274454B1 (ja)
FR2264545B1 (ja)
FR2284269B3 (ja)
JPS50103428A (ja)
AU495920B2 (ja)
AU7138274A (ja)
AU7099174A (ja)
FI222574A (ja)
AU481101A (ja)
BG19607A1 (ja)
AU480209A (ja)
AU480469A (ja)
AU480580A (ja)
AU481044A (ja)
AU481082A (ja)
AU481340A (ja)
AU481457A (ja)
AU481580A (ja)
AU482019A (ja)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD.